arginine and salicylsalicylic acid

arginine has been researched along with salicylsalicylic acid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barzilay, JI; Fonseca, V; Goldfine, AB; Jablonski, KA; Monnier, VM; Shoelson, SE; Strauch, C	1
de Crom, R; Habib, SL; Janardhanan, P; Krishnan, M; Mohan, S; Natarajan, M; Reddick, RL; Roman, L; van Haperen, R	1

Reviews

1 review(s) available for arginine and salicylsalicylic acid

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for arginine and salicylsalicylic acid

Article	Year
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes. Diabetes care, 2014, Volume: 37, Issue:4 Topics: Adiponectin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyruvaldehyde; Salicylates	2014

Article

Year

The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.

Diabetes care, 2014, Volume: 37, Issue:4

Topics: Adiponectin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyruvaldehyde; Salicylates

2014

Other Studies

1 other study(ies) available for arginine and salicylsalicylic acid

Article	Year
Enhancing eNOS activity with simultaneous inhibition of IKKβ restores vascular function in Ins2(Akita+/-) type-1 diabetic mice. Laboratory investigation; a journal of technical methods and pathology, 2015, Volume: 95, Issue:10 Topics: Animals; Aorta; Arginine; Cattle; Cells, Cultured; Diabetes Mellitus, Type 1; Dietary Supplements; Endothelium, Vascular; Female; Heterozygote; Humans; Hypoglycemic Agents; Insulin; Male; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide Synthase Type III; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pterins; Recombinant Fusion Proteins; Salicylates; Weaning	2015

Article

Year

Enhancing eNOS activity with simultaneous inhibition of IKKβ restores vascular function in Ins2(Akita+/-) type-1 diabetic mice.

Laboratory investigation; a journal of technical methods and pathology, 2015, Volume: 95, Issue:10

Topics: Animals; Aorta; Arginine; Cattle; Cells, Cultured; Diabetes Mellitus, Type 1; Dietary Supplements; Endothelium, Vascular; Female; Heterozygote; Humans; Hypoglycemic Agents; Insulin; Male; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide Synthase Type III; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pterins; Recombinant Fusion Proteins; Salicylates; Weaning

2015